Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Alimera Sciences Inc

+ Add to Watchlist


4.1800 USD 0.0700 1.70%

As of 15:32:39 ET on 06/02/2015.

Company Profile for Alimera Sciences Inc (ALIM)

Alimera Sciences Inc. is a biopharmaceutical company. The Company researches, develops and commercializes prescription ophthalmic pharmaceuticals. Alimera Sciences is focused on diseases affecting the lining in the back of the eye, or retina.

Contact Information

Alimera Sciences Inc

6120 Windward Parkway
Suite 290
Alpharetta, GA 30005
United States
Phone: 1-678-990-5740
Fax: 1-678-990-5744

Key Executives for Alimera Sciences Inc (ALIM)

C Daniel Myers "Dan"President/CEO/Co-FounderRichard S Eiswirth Jr "Rick"CFO/COO/Secretary
Kenneth Green "Ken"Senior VP/Chief Scientific OfcrDavid Holland "Dave"Senior VP:Sales & Marketing
Susan CaballaSenior VP:Regulatory AffairsPhilip AshmanSenior VP/Mng Dir:Europe

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil